ALS Research

Home/ALS Research

Big News: Approval of AMX0035 by FDA Advisory Committee

The FDA advisory committee recently approved the use of AMX0035 for the treatment of ALS. Presented with the robustness of new evidence, the committee reversed their March 2022 vote overwhelming by a 7-2 vote. The ALS Association has publicly thanked both the FDA advisory committee and the entire ALS community for their hard work and advocacy. Read Full Article

2022-09-12T20:31:11+00:00September 12th, 2022|

Research on Chinese Herbal Prescription for ALS Treatment

Read this article from the National Library of Medicine to learn about a case of ALS patient using modified Dihuang Yinzi (DHYZ), a classical traditional Chinese medicine (TCM) prescription.  This person has survived 12 years with significant improvement in bulbar paralysis.

2022-07-26T21:23:41+00:00May 26th, 2016|